BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV

NCT02817802 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2066

Last updated 2023-02-10

No results posted yet for this study

Summary

The registry will investigate the clinical performance and long-term safety of Magmaris in a real world setting

Conditions

Interventions

DEVICE

Magmaris

PCI (Magmaris)

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Stefan Verheye, MD · Cardiovascular Institute Middelheim, Antwerpen, Belgium

  • Michael Kang-Yin Lee, MD · Queen Elizabeth Hospital, Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2020-07-14
Completion
2025-10-31

Countries

  • Belgium
  • Hong Kong

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02817802 on ClinicalTrials.gov